NDARC is part of a new research project led by the University of Tasmania seeking to understand how codeine sales restrictions will affect codeine consumers and health professionals.
In August this year, the Therapeutic Goods Administration made the interim decision to move all over the counter codeine medications to prescription-only medicines (Schedule 4).
This interim decision was made on the basis of concerns regarding risk of dependence and side-effects with codeine use and the known availability of safer over the counter products.
The research team, NDARC’s Dr Suzanne Nielsen, University of Tasmania PhD candidate in the School of Psychology Jacqui McCoy and supervisor Associate Professor Raimondo Bruno developed a questionnaire for health professionals and people who use codeine.
Those affected are encouraged to fill out the survey, which can be found at: https://surveys.utas.edu.au/index.php/677193?lang=en.
For more information, visit the UTAS media release at http://www.media.utas.edu.au/general-news/all-news/research-to-understand-the-effects-of-codeine-sales-restrictions.